Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Dennis Ross-Degnan, Sc.D.

TitleAssociate Professor of Population Medicine
InstitutionHarvard Pilgrim Healthcare
DepartmentPopulation Medicine
AddressHarvard Medical School and Harvard Pilgrim Health Care
Dept. of Population Medicine, 6th Floor
133 Brookline Ave
Boston MA 02215
Phone617/509-9920
Fax617/859-8112

 Biography 
 awards and honors
1968 - 1972Presidential Scholarship
1971 - 1972Scholar of the College
1977 - 1979Kellogg Fellow
1979 - 1980Sinclair Kennedy Traveling Fellow
1984 - 1986International Eye Foundation Fellow
1991 - Article of the Year Award
1996 - Article of the Year Award
2005 - Klaus Peter International Teaching Award

 Mentoring 
 completed student projects
Prescribing Patterns and Cost of Anti-hypertensive Medications in the Philippines in PhilHealth, a Large National Insurer
International, 06/20/08 - 08/15/08
HIV/AIDS and Antiretroviral Education in Namugongo, Uganda
International, 06/28/05 - 08/23/05
The Culture of Neurology in a Hospital in Beijing, China: An Ethnographic Study
International, 02/15/08 - 05/15/08

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wharam JF. Impact of a High-deductible Health Plan on Outpatient Visits and Associated Diagnostic Tests. Med Care. 2014 Jan; 52(1):86-92.
    View in: PubMed
  2. Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Degnan D, Buist DS, Rosenberg MA, Alfisher M, Fletcher SW. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med. 2014 Jan 1; 174(1):114-21.
    View in: PubMed
  3. Wharam JF, Ross-Degnan D, Rosenthal MB. The ACA and high-deductible insurance--strategies for sharpening a blunt instrument. N Engl J Med. 2013 Oct 17; 369(16):1481-4.
    View in: PubMed
  4. Balaban R, Galbraith A, Burns M, Vialle-Valentin C, Friedman E, Ross-Degnan D. C2-1: a randomized controlled trial of a patient navigator intervention to reduce hospital readmissions in a safety net health care system. Clin Med Res. 2013 Sep; 11(3):157-8.
    View in: PubMed
  5. Fretheim A, Soumerai SB, Zhang F, Oxman AD, Ross-Degnan D. Interrupted time-series analysis yielded an effect estimate concordant with the cluster-randomized controlled trial result. J Clin Epidemiol. 2013 Aug; 66(8):883-7.
    View in: PubMed
  6. Wharam JF, Zhang F, Landon BE, Soumerai SB, Ross-Degnan D. Low-socioeconomic-status enrollees in high-deductible plans reduced high-severity emergency care. Health Aff (Millwood). 2013 Aug; 32(8):1398-406.
    View in: PubMed
  7. Chalker JC, Wagner AK, Tomson G, Johnson K, Wahlström R, Ross-Degnan D. Appointment systems are essential for improving chronic disease care in resource-poor settings: learning from experiences with HIV patients in Africa. Int Health. 2013 Sep; 5(3):163-5.
    View in: PubMed
  8. Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AK. Health care payments in the asia pacific: validation of five survey measures of economic burden. Int J Equity Health. 2013; 12:49.
    View in: PubMed
  9. Boruett P, Kagai D, Njogo S, Nguhiu P, Awuor C, Gitau L, Chalker J, Ross-Degnan D, Wahlström R, Tomson G. Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya-a quasi-experimental study using time series analysis. BMC Health Serv Res. 2013; 13:242.
    View in: PubMed
  10. Blanchard J, Madden JM, Ross-Degnan D, Gresenz CR, Soumerai SB. The relationship between emergency department use and cost-related medication nonadherence among medicare beneficiaries. Ann Emerg Med. 2013 Nov; 62(5):475-85.
    View in: PubMed
  11. Galbraith AA, Sinaiko AD, Soumerai SB, Ross-Degnan D, Dutta-Linn MM, Lieu TA. Some families who purchased health coverage through the massachusetts connector wound up with high financial burdens. Health Aff (Millwood). 2013 May; 32(5):974-83.
    View in: PubMed
  12. Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan D. Need for and access to health care and medicines: are there gender inequities? PLoS One. 2013; 8(3):e57228.
    View in: PubMed
  13. Stephens P, Ross-Degnan D, Wagner AK. Does access to medicines differ by gender? Evidence from 15 low and middle income countries. Health Policy. 2013 Apr; 110(1):60-6.
    View in: PubMed
  14. Wharam JF, Soumerai S, Trinacty C, Eggleston E, Zhang F, Lecates R, Canning C, Ross-Degnan D. Impact of emerging health insurance arrangements on diabetes outcomes and disparities: rationale and study design. Prev Chronic Dis. 2013 Jan; 10:E11.
    View in: PubMed
  15. Sinaiko AD, Ross-Degnan D, Soumerai SB, Lieu T, Galbraith A. The experience of massachusetts shows that consumers will need help in navigating insurance exchanges. Health Aff (Millwood). 2013 Jan; 32(1):78-86.
    View in: PubMed
  16. Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012; 2(6).
    View in: PubMed
  17. Pérez-Cuevas R, Doubova SV, Suarez-Ortega M, Law M, Pande AH, Escobedo J, Espinosa-Larrañaga F, Ross-Degnan D, Wagner AK. Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico. BMC Med Inform Decis Mak. 2012; 12:50.
    View in: PubMed
  18. Wharam JF, Graves AJ, Zhang F, Soumerai SB, Ross-Degnan D, Landon BE. Two-year trends in cancer screening among low socioeconomic status women in an HMO-based high-deductible health plan. J Gen Intern Med. 2012 Sep; 27(9):1112-9.
    View in: PubMed
  19. Galbraith AA, Soumerai SB, Ross-Degnan D, Rosenthal MB, Gay C, Lieu TA. Delayed and forgone care for families with chronic conditions in high-deductible health plans. J Gen Intern Med. 2012 Sep; 27(9):1105-11.
    View in: PubMed
  20. Zhang F, Wagner AK, Ross-Degnan D. Simulation-based power calculation for designing interrupted time series analyses of health policy interventions. J Clin Epidemiol. 2011 Nov; 64(11):1252-61.
    View in: PubMed
  21. Vialle-Valentin CE, Lecates RF, Zhang F, Desta AT, Ross-Degnan D. Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countries. Trop Med Int Health. 2012 Feb; 17(2):211-22.
    View in: PubMed
  22. Wharam JF, Landon BE, Zhang F, Soumerai SB, Ross-Degnan D. High-deductible insurance: two-year emergency department and hospital use. Am J Manag Care. 2011 Oct; 17(10):e410-8.
    View in: PubMed
  23. Briesacher BA, Zhao Y, Madden JM, Zhang F, Adams AS, Tjia J, Ross-Degnan D, Gurwitz JH, Soumerai SB. Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care. 2011 Sep; 49(9):834-41.
    View in: PubMed
  24. Wharam JF, Graves AJ, Landon BE, Zhang F, Soumerai SB, Ross-Degnan D. Two-year trends in colorectal cancer screening after switch to a high-deductible health plan. Med Care. 2011 Sep; 49(9):865-71.
    View in: PubMed
  25. Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat. 2011 Nov; 130(2):681-9.
    View in: PubMed
  26. Nekhlyudov L, Madden J, Graves AJ, Zhang F, Soumerai SB, Ross-Degnan D. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors. J Cancer Surviv. 2011 Dec; 5(4):395-404.
    View in: PubMed
  27. Pande AH, Ross-Degnan D, Zaslavsky AM, Salomon JA. Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts. Am J Prev Med. 2011 Jul; 41(1):1-8.
    View in: PubMed
  28. Reiss SK, Ross-Degnan D, Zhang F, Soumerai SB, Zaslavsky AM, Wharam JF. Effect of switching to a high-deductible health plan on use of chronic medications. Health Serv Res. 2011 Oct; 46(5):1382-401.
    View in: PubMed
  29. Lu CY, Adams AS, Ross-Degnan D, Zhang F, Zhang Y, Salzman C, Soumerai SB. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv. 2011 Feb; 62(2):186-93.
    View in: PubMed
  30. Galbraith AA, Ross-Degnan D, Soumerai SB, Rosenthal MB, Gay C, Lieu TA. Nearly half of families in high-deductible health plans whose members have chronic conditions face substantial financial burden. Health Aff (Millwood). 2011 Feb; 30(2):322-31.
    View in: PubMed
  31. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, Soumerai SB. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ. 2011; 342:d108.
    View in: PubMed
  32. Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2011 Jan; 33(1):135-44.
    View in: PubMed
  33. Kozhimannil KB, Huskamp HA, Graves AJ, Soumerai SB, Ross-Degnan D, Wharam JF. High-deductible health plans and costs and utilization of maternity care. Am J Manag Care. 2011; 17(1):e17-25.
    View in: PubMed
  34. Kozhimannil KB, Huskamp HA, Graves AJ, Soumerai SB, Ross-Degnan D, Wharam JF. High-deductible health plans and costs and utilization of maternity care. Am J Manag Care. 2011 Jan; 17(1):e17-25.
    View in: PubMed
  35. Faden L, Vialle-Valentin C, Ross-Degnan D, Wagner A. Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence. Health Policy. 2011 May; 100(2-3):134-43.
    View in: PubMed
  36. Carapinha JL, Ross-Degnan D, Desta AT, Wagner AK. Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making. Health Policy. 2011 Mar; 99(3):193-202.
    View in: PubMed
  37. Galbraith AA, Ross-Degnan D, Soumerai SB, Abrams AM, Kleinman K, Rosenthal MB, Wharam JF, Adams AS, Miroshnik I, Lieu TA. Use of well-child visits in high-deductible health plans. Am J Manag Care. 2010 Nov; 16(11):833-40.
    View in: PubMed
  38. Zhang F, Wharam JF, Ross-Degnan D. Comparing simulation and threshold approaches when analysing data with probabilities of categories. J Eval Clin Pract. 2010 Oct; 16(5):964-7.
    View in: PubMed
  39. Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy. 2011 May; 100(2-3):151-8.
    View in: PubMed
  40. Bertoldi AD, Barros AJ, Camargo AL, Hallal PC, Vandoros S, Wagner A, Ross-Degnan D. Household expenditures for medicines and the role of free medicines in the Brazilian public health system. Am J Public Health. 2011 May; 101(5):916-21.
    View in: PubMed
  41. Chen W, Tang S, Sun J, Ross-Degnan D, Wagner AK. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv Res. 2010; 10:211.
    View in: PubMed
  42. Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SB. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy. Med Care. 2010 Jun; 48(6):503-9.
    View in: PubMed
  43. Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2010 Apr; 32(4):729-41; discussion 716.
    View in: PubMed
  44. Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D. Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology. Rev Panam Salud Publica. 2010 Apr; 27(4):291-9.
    View in: PubMed
  45. Simon SR, Trinacty CM, Soumerai SB, Piette JD, Meigs JB, Shi P, Ensroth A, Ross-Degnan D. Improving diabetes care among patients overdue for recommended testing: a randomized controlled trial of automated telephone outreach. Diabetes Care. 2010 Jul; 33(7):1452-3.
    View in: PubMed
  46. Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, Balikuddembe R, Chalker J, Wagner AK. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010; 10:42.
    View in: PubMed
  47. Chalker JC, Andualem T, Gitau LN, Ntaganira J, Obua C, Tadeg H, Waako P, Ross-Degnan D. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010; 10:43.
    View in: PubMed
  48. Simon SR, Zhang F, Soumerai SB, Ensroth A, Bernstein L, Fletcher RH, Ross-Degnan D. Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2010 Feb 8; 170(3):264-70.
    View in: PubMed
  49. Chalker J, Wagner A, Tomson G, Laing R, Johnson K, Wahlström R, Ross-Degnan D. Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators. J Acquir Immune Defic Syndr. 2010 Feb; 53(2):159-61.
    View in: PubMed
  50. Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS. Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care. 2010 Jan; 48(1):4-9.
    View in: PubMed
  51. Briesacher B, Ross-Degnan D, Adams A, Wagner A, Gurwitz J, Soumerai S. A new measure of medication affordability. Soc Work Public Health. 2009 Nov-Dec; 24(6):600-12.
    View in: PubMed
  52. Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA. 2009 Oct 28; 302(16):1755-6.
    View in: PubMed
  53. Fortuna RJ, Zhang F, Ross-Degnan D, Campion FX, Finkelstein JA, Kotch JB, Feldstein AC, Smith DH, Simon SR. Reducing the prescribing of heavily marketed medications: a randomized controlled trial. J Gen Intern Med. 2009 Aug; 24(8):897-903.
    View in: PubMed
  54. Adams AS, Zhang F, LeCates RF, Graves AJ, Ross-Degnan D, Gilden D, McLaughlin TJ, Lu C, Trinacty CM, Soumerai SB. Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees. Arch Intern Med. 2009 Apr 27; 169(8):750-6.
    View in: PubMed
  55. Zhang Y, Adams AS, Ross-Degnan D, Zhang F, Soumerai SB. Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. Psychiatr Serv. 2009 Apr; 60(4):520-7.
    View in: PubMed
  56. Galbraith AA, Ross-Degnan D, Soumerai SB, Miroshnik I, Wharam JF, Kleinman K, Lieu TA. High-deductible health plans: are vulnerable families enrolled? Pediatrics. 2009 Apr; 123(4):e589-94.
    View in: PubMed
  57. Kozhimannil KB, Valera MR, Adams AS, Ross-Degnan D. The population-level impacts of a national health insurance program and franchise midwife clinics on achievement of prenatal and delivery care standards in the Philippines. Health Policy. 2009 Sep; 92(1):55-64.
    View in: PubMed
  58. Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, Piette JD, Ross-Degnan D. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009; 9:24.
    View in: PubMed
  59. Briesacher B, Ross-Degnan D, Adams AS, Wagner AK, Gurwitz JH, Soumerai SB. Redefining the affordability of medication expenditures among Medicaid enrollees. J Hlth and Soc Policy Review. 2008; (in press).
  60. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2009 Feb; 62(2):143-8.
    View in: PubMed
  61. Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res. 2008; 8:222.
    View in: PubMed
  62. Vialle-Valentin CE, Ross-Degnan D, Ntaganira J, Wagner AK. Medicines coverage and community-based health insurance in low-income countries. Health Res Policy Syst. 2008; 6:11.
    View in: PubMed
  63. Bertoldi AD, de Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. 2009 Mar; 89(3):295-302.
    View in: PubMed
  64. Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. 2008; 8:161.
    View in: PubMed
  65. Chalker J, Andualem T, Minzi O, Ntaganira J, Ojoo A, Waako P, Ross-Degnan D. Monitoring adherence and defaulting for antiretroviral therapy in 5 East african countries: an urgent need for standards. J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug; 7(4):193-9.
    View in: PubMed
  66. Morden NE, Zerzan JT, Rue TC, Heagerty PJ, Roughead EE, Soumerai SB, Ross-Degnan D, Sullivan SD. Medicaid prior authorization and controlled-release oxycodone. Med Care. 2008 Jun; 46(6):573-80.
    View in: PubMed
  67. Goldman RE, Sanchez-Hernandez M, Ross-Degnan D, Piette JD, Trinacty CM, Simon SR. Developing an automated speech-recognition telephone diabetes intervention. Int J Qual Health Care. 2008 Aug; 20(4):264-70.
    View in: PubMed
  68. Wharam JF, Galbraith AA, Kleinman KP, Soumerai SB, Ross-Degnan D, Landon BE. Cancer screening before and after switching to a high-deductible health plan. Ann Intern Med. 2008 May 6; 148(9):647-55.
    View in: PubMed
  69. Fortuna RJ, Ross-Degnan D, Finkelstein J, Zhang F, Campion FX, Simon SR. Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice. J Eval Clin Pract. 2008 Dec; 14(6):969-73.
    View in: PubMed
  70. Law MR, Ross-Degnan D, Soumerai SB. Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements. Psychiatr Serv. 2008 May; 59(5):540-6.
    View in: PubMed
  71. Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, Gurwitz JH, Pierre-Jacques M, Safran DG, Adler GS, Soumerai SB. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008 Apr 23; 299(16):1922-8.
    View in: PubMed
  72. Lu CY, Ross-Degnan D, Soumerai SB, Pearson SA. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Serv Res. 2008; 8:75.
    View in: PubMed
  73. Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law MR, Hughes TE, Chapman D, Adams AS. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Aff (Millwood). 2008 May-Jun; 27(3):w185-95.
    View in: PubMed
  74. Pierre-Jacques M, Safran DG, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Rusinak D, Soumerai SB. Reliability of new measures of cost-related medication nonadherence. Med Care. 2008 Apr; 46(4):444-8.
    View in: PubMed
  75. Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Gurwitz JH. Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med. 2008 Jun; 23(6):709-14.
    View in: PubMed
  76. Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, Soumerai SB, Ross-Degnan D. Medication adherence and racial differences in A1C control. Diabetes Care. 2008 May; 31(5):916-21.
    View in: PubMed
  77. Chalker J, Andualem T, Minzi O, Ntaganira J, Ojoo A, Waako P, Ross-Degnan D. Monitoring adherence and defaulting for antiretroviral therapy in five East African countries: An urgent need for standards. J Int Assoc Physicians AIDS Care (in press). 2008.
  78. Ross-Degnan D, Backes-Kozhimannil K, Payson A, Aupont O, LeCates R, Chalker J, Briggs J. Improving community use of medicines in the management of child illness: A guide to developing interventions. 2008.
  79. Law MR, Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry. 2008 Jan; 69(1):47-53.
    View in: PubMed
  80. Wagner A, Ross-Degnan D. The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries and the WHO Collaborating Center Medicines and Insurance Coverage (MedIC) Initiative. Eggleston K (Ed.) Pharmaceuticals in the Asia-Pacific: Prescribing Cultures, Industry Dynamics, and Health Policy. 2008; (in press).
  81. Finkelstein JA, Huang SS, Kleinman K, Rifas-Shiman SL, Stille CJ, Daniel J, Schiff N, Steingard R, Soumerai SB, Ross-Degnan D, Goldmann D, Platt R. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008 Jan; 121(1):e15-23.
    View in: PubMed
  82. Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, Piette JD, Ross-Degnan D. Racial differences in long-term self-monitoring practice among newly drug-treated diabetes patients in an HMO. J Gen Intern Med. 2007 Nov; 22(11):1506-13.
    View in: PubMed
  83. Srivastava R, Landrigan CP, Ross-Degnan D, Soumerai SB, Homer CJ, Goldmann DA, Muret-Wagstaff S. Impact of a hospitalist system on length of stay and cost for children with common conditions. Pediatrics. 2007 Aug; 120(2):267-74.
    View in: PubMed
  84. Bambauer KZ, Soumerai SB, Adams AS, Zhang F, Ross-Degnan D. Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty. J Clin Psychiatry. 2007 Jun; 68(6):867-73.
    View in: PubMed
  85. Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, Pierre-Jacques M, Soumerai SB. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007 May; 64(5):602-8.
    View in: PubMed
  86. Elliott RA, Ross-Degnan D, Adams AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007 Jun; 22(6):805-10.
    View in: PubMed
  87. Wharam JF, Landon BE, Galbraith AA, Kleinman KP, Soumerai SB, Ross-Degnan D. Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. JAMA. 2007 Mar 14; 297(10):1093-102.
    View in: PubMed
  88. Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007 Apr; 30(4):807-12.
    View in: PubMed
  89. Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, Soumerai SB. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007 Jan 16; 146(2):96-103.
    View in: PubMed
  90. Taveras EM, Sandora TJ, Shih MC, Ross-Degnan D, Goldmann DA, Gillman MW. The association of television and video viewing with fast food intake by preschool-age children. Obesity (Silver Spring). 2006 Nov; 14(11):2034-41.
    View in: PubMed
  91. Zerzan JT, Morden NE, Soumerai S, Ross-Degnan D, Roughead E, Zhang F, Simoni-Wastila L, Sullivan SD. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006 Nov; 44(11):1005-10.
    View in: PubMed
  92. Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Adler G, Safran DG. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006 Sep 25; 166(17):1829-35.
    View in: PubMed
  93. Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med. 2006 Jul; 119(7):607-15.
    View in: PubMed
  94. Mah CA, Soumerai SB, Adams AS, Ross-Degnan D. Racial differences in impact of coverage on diabetes self-monitoring in a health maintenance organization. Med Care. 2006 May; 44(5):392-7.
    View in: PubMed
  95. Roughead EE, Zhang F, Ross-Degnan D, Soumerai S. Differential effect of early or late implementation of prior authorization policies on the use of Cox II inhibitors. Med Care. 2006 Apr; 44(4):378-82.
    View in: PubMed
  96. Sequist TD, Adams A, Zhang F, Ross-Degnan D, Ayanian JZ. Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med. 2006 Mar 27; 166(6):675-81.
    View in: PubMed
  97. Bambauer KZ, Adams AS, Zhang F, Minkoff N, Grande A, Weisblatt R, Soumerai SB, Ross-Degnan D. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med. 2006 Mar 13; 166(5):498-504.
    View in: PubMed
  98. Pearson SA, Soumerai S, Mah C, Zhang F, Simoni-Wastila L, Salzman C, Cosler LE, Fanning T, Gallagher P, Ross-Degnan D. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med. 2006 Mar 13; 166(5):572-9.
    View in: PubMed
  99. Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ. 2006 Jan 21; 332(7534):141-5.
    View in: PubMed
  100. Prepared and edited by Marsha Pierre-Jacques, Anita Wagner, Dennis Ross-Degnan, Edelisa D Carandang. . World Health Organization Department of Technical Cooperation on Essential Drugs and Traditional Medicines. Using Indicators to Measure Country Pharmaceutical Situations: Fact Book on WHO Level I and Level II Monitoring Indicators. 2006.
  101. Aaserud M, Dahlgren AT, Sturm H, Kösters JP, Hill S, Furberg CD, Grilli R, Henry DA, Oxman AD, Ramsay C, Ross-Degnan D, Soumerai SB. Pharmaceutical policies: effects on rational drug use, an overview of 13 reviews. (Protocol). Cochrane Database of Systematic Reviews. 2006; (2).
  102. Adams AS, Zhang F, Mah C, Grant RW, Kleinman K, Meigs JB, Ross-Degnan D. Race differences in long-term diabetes management in an HMO. Diabetes Care. 2005 Dec; 28(12):2844-9.
    View in: PubMed
  103. Sandora TJ, Taveras EM, Shih MC, Resnick EA, Lee GM, Ross-Degnan D, Goldmann DA. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics. 2005 Sep; 116(3):587-94.
    View in: PubMed
  104. Park S, Ross-Degnan D, Adams AS, Sabin J, Kanavos P, Soumerai SB. Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: population-based study. Br J Psychiatry. 2005 Aug; 187:137-42.
    View in: PubMed
  105. Park S, Soumerai SB, Adams AS, Finkelstein JA, Jang S, Ross-Degnan D. Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan. 2005 Sep; 20(5):302-9.
    View in: PubMed
  106. Majumdar SR, Ross-Degnan D, Farraye FA, Lee M, Kemp JA, Lecates RF, Henning JM, Tunis SR, Schrammel P, Soumerai SB. Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms. Aliment Pharmacol Ther. 2005 Apr 15; 21(8):1029-39.
    View in: PubMed
  107. Lee GM, Salomon JA, Friedman JF, Hibberd PL, Ross-Degnan D, Zasloff E, Bediako S, Goldmann DA. Illness transmission in the home: a possible role for alcohol-based hand gels. Pediatrics. 2005 Apr; 115(4):852-60.
    View in: PubMed
  108. Suttajit S, Wagner AK, Tantipidoke R, Ross-Degnan D, Sitthi-amorn C. Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok. Southeast Asian J Trop Med Public Health. 2005 Mar; 36(2):489-97.
    View in: PubMed
  109. Suryawati S, Ross-Degnan D, Timmermans K, Slamet LS, Nurita P, Hogerzeil H . Impact of the currency crisis on medicine cost and availability of key essential medicines in Indonesia 1997–2002. 2005.
  110. Suryawati S, Ross-Degnan D, Timmermans K, Slamet LS, Nurita P, Hogerzeil H. Impact of the currency crisis on medicine cost and availability of key essential medicines in Indonesia 1997–2002. 2005.
  111. Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14):1567-72.
    View in: PubMed
  112. Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, Ross-Degnan D. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med. 2004 Mar 22; 164(6):645-52.
    View in: PubMed
  113. Ogwal-Okeng JW, Obua C, Waako P, Aupont O, Ross-Degnan D. A comparison of prescribing practices between public and private sector physicians in Uganda. East Afr Med J. 2004 Feb; Suppl:S12-6.
    View in: PubMed
  114. Obua C, Ogwal-Okeng JW, Waako P, Aupont O, Ross-Degnan D. Impact of an educational intervention to improve prescribing by private physicians in Uganda. East Afr Med J. 2004 Feb; Suppl:S17-24.
    View in: PubMed
  115. Anokbonggo WW, Ogwal-Okeng JW, Ross-Degnan D, Aupont O. Attitudes and perceptions of stakeholders on decentralization of health services in Uganda: the case of Lira and Apac districts. East Afr Med J. 2004 Feb; Suppl:S8-11.
    View in: PubMed
  116. Anokbonggo WW, Ogwal-Okeng JW, Obua C, Aupont O, Ross-Degnan D. Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs. East Afr Med J. 2004 Feb; Suppl:S2-7.
    View in: PubMed
  117. Simoni-Wastila L, Ross-Degnan D, Mah C, Gao X, Brown J, Cosler LE, Fanning T, Gallagher P, Salzman C, Soumerai SB. A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. Clin Ther. 2004 Feb; 26(2):322-36.
    View in: PubMed
  118. Ross-Degnan D, Simoni-Wastila L, Brown JS, Gao X, Mah C, Cosler LE, Fanning T, Gallagher P, Salzman C, Shader RI, Inui TS, Soumerai SB. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med. 2004; 34(2):103-23.
    View in: PubMed
  119. Madden JM, Soumerai SB, Lieu TA, Mandl KD, Zhang F, Ross-Degnan D. Length-of-stay policies and ascertainment of postdischarge problems in newborns. Pediatrics. 2004 Jan; 113(1 Pt 1):42-9.
    View in: PubMed
  120. Kanavos P, Soumerai SB, Fortess EE, Abelson J, Ross-Degnan D. . Measuring, monitoring, and evaluating policy outcomes in the pharmaceutical sector. (invited chapter). Regulating the cost and use of pharmaceuticals in Europe: Containing costs while improving efficiency, quality and equity. Mossialos E, Mrazek M, and Walley T, eds. 2004.
  121. Majumdar SR, Soumerai SB, Farraye FA, Lee M, Kemp JA, Henning JM, Schrammel P, LeCates RF, Ross-Degnan D. Chronic acid-related disorders are common and underinvestigated. Am J Gastroenterol. 2003 Nov; 98(11):2409-14.
    View in: PubMed
  122. Pearson SA, Ross-Degnan D, Payson A, Soumerai SB. Changing medication use in managed care: a critical review of the available evidence. Am J Manag Care. 2003 Nov; 9(11):715-31.
    View in: PubMed
  123. Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, Fanning T, Gallagher P, Ross-Degnan D. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care. 2003 Oct; 15(5):423-31.
    View in: PubMed
  124. Sinha A, Madden J, Ross-Degnan D, Soumerai S, Platt R. Reduced risk of neonatal respiratory infections among breastfed girls but not boys. Pediatrics. 2003 Oct; 112(4):e303.
    View in: PubMed
  125. Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D. Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv. 2003 Jul; 54(7):1006-11.
    View in: PubMed
  126. Adams AS, Mah C, Soumerai SB, Zhang F, Barton MB, Ross-Degnan D. Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study. BMC Health Serv Res. 2003 Mar 19; 3(1):6.
    View in: PubMed
  127. Madden JM, Soumerai SB, Lieu TA, Mandl KD, Zhang F, Ross-Degnan D. Effects on breastfeeding of changes in maternity length-of-stay policy in a large health maintenance organization. Pediatrics. 2003 Mar; 111(3):519-24.
    View in: PubMed
  128. Nekhlyudov L, Ross-Degnan D, Fletcher SW. Beliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study. J Gen Intern Med. 2003 Mar; 18(3):182-9.
    View in: PubMed
  129. Lee GM, Friedman JF, Ross-Degnan D, Hibberd PL, Goldmann DA. Misconceptions about colds and predictors of health service utilization. Pediatrics. 2003 Feb; 111(2):231-6.
    View in: PubMed
  130. Nachbar N, Briggs J, Aupont O, Shafritz L, Bongiovanni A, Acharya K, Zimicki S, Holschneider S, Ross-Degnan D. Community drug management for childhood illness: Assessment manual. 2003.
  131. Nachbar N, Briggs J, Aupont O, Shafritz L, Bongiovanni A, Acharya K, Zimicki S, Holschneider S, Ross-Degnan D. Community drug management for childhood illness: Assessment manual. 2003.
  132. Madden JM, Ross-Degnan D, Soumerai SB. 2003; 348:1602-3. . Effects of a law against early postpartum discharge. (Correspondence). N Engl J Med. 2003; 348:1602-3.
  133. Medicine Prices Project Working Group. Medicine prices: A new approach to measurement. 2003.
  134. Isah AO, Laing R, Quick J, Mabadeje AFB, Hogerzeil H, Ross-Degnan D. The development of reference values for the WHO Health Facility Core Prescribing Indicators. West African Journal of Pharmacology and Drug Research. 2003; 18:6-11.
  135. Medicine Prices Project Working Group. Medicine prices: A new approach to measurement. (WHO/EDM/PAR/2003.2). 2003.
  136. Madden JM, Soumerai SB, Lieu TA, Mandl KD, Zhang F, Ross-Degnan D. Effects of a law against early postpartum discharge on newborn follow-up, adverse events, and HMO expenditures. N Engl J Med. 2002 Dec 19; 347(25):2031-8.
    View in: PubMed
  137. Landrigan CP, Srivastava R, Muret-Wagstaff S, Soumerai SB, Ross-Degnan D, Graef JW, Homer CJ, Goldmann DA. Impact of a health maintenance organization hospitalist system in academic pediatrics. Pediatrics. 2002 Oct; 110(4):720-8.
    View in: PubMed
  138. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002 Aug; 27(4):299-309.
    View in: PubMed
  139. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med. 2002 Mar 11; 162(5):561-8.
    View in: PubMed
  140. Zhang F, Wagner A, Soumerai SB, Ross-Degnan D . Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. NESUG Fifteenth Annual Conference Proceedings. 2002; 748-54.
  141. Zhang F, Wagner A, Soumerai SB, Ross-Degnan D. Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. 2002.
  142. Soumerai SB, Adams AS, Ross-Degnan D. Medicare prescription coverage and congressional gridlock. J Gen Intern Med. 2001 Dec; 16(12):864-6.
    View in: PubMed
  143. Weinberg M, Fuentes JM, Ruiz AI, Lozano FW, Angel E, Gaitan H, Goethe B, Parra S, Hellerstein S, Ross-Degnan D, Goldmann DA, Huskins WC. Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods. Arch Intern Med. 2001 Oct 22; 161(19):2357-65.
    View in: PubMed
  144. Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA. 2001 Oct 10; 286(14):1732-9.
    View in: PubMed
  145. Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, Soumerai S, Ross-Degnan D, Andrade S, Goodman MJ, Martinson B, Raebel MA, Smith D, Ulcickas-Yood M, Chan KA. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7.
    View in: PubMed
  146. Majumdar SR, Soumerai SB, Lee M, Ross-Degnan D. Designing an intervention to improve the management of Helicobacter pylori infection. Jt Comm J Qual Improv. 2001 Aug; 27(8):405-14.
    View in: PubMed
  147. Fortess EE, Soumerai SB, McLaughlin TJ, Ross-Degnan D. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting. J Am Geriatr Soc. 2001 Jun; 49(6):793-7.
    View in: PubMed
  148. Laing R, Hogerzeil H, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001 Mar; 16(1):13-20.
    View in: PubMed
  149. Adams AS, Soumerai SB, Ross-Degnan D. Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter? Health Aff (Millwood). 2001 Jan-Feb; 20(1):276-86.
    View in: PubMed
  150. Adams AS, Soumerai SB, Ross-Degnan D. The case for a medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health. 2001; 22:49-61.
    View in: PubMed
  151. Ross-Degnan D. Changing behavior to maintain a healthy home. Pediatr Infect Dis J. 2000 Oct; 19(10 Suppl):S117-9.
    View in: PubMed
  152. Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. Coverage by the news media of the benefits and risks of medications. N Engl J Med. 2000 Jun 1; 342(22):1645-50.
    View in: PubMed
  153. Ross-Degnan D. Contributions of behavioral perspectives to research on improving use of medicines. Darwin M, Wattie AM, Prawitasari YE, Abdullah I, Sukadmi, Faturochman, Eds. Health Social Science Action and Partnership: Retrospective and Prospective Discourse (APSSAM IV Proceedings). 2000.
  154. Koide D, Ohe K, Ross-Degnan D, Kaihara S. Computerized reminders to monitor liver function to improve the use of etretinate. Int J Med Inform. 2000 Jan; 57(1):11-9.
    View in: PubMed
  155. Thuo HM, Fujisaki T, Ross-Degnan D, Beracochea E. Role of the pharmacist in antenatal care: Evidence from a simulated purchase study from community pharmacy settings in Nairobi and its environs. Health Line. 2000; 4(2):25-29.
  156. Ross-Degnan D. Sociology of changing behavior to maintain a healthy home. Invited presentation at The Health Home Summit: The significance of cleanliness and disinfection in the home and its link to infection control, New York, NY. 1999.
  157. Ross-Degnan D, Soumerai S. Drug cost containment and quality improvement in managed care organizations: Lessons from research. Invited presentation at the Pharmacy Management: Reducing the Rise of Costs in the New Millennium, Pharmacare Annual Conference, Boston, MA. 1999.
  158. Soumerai SB, McLaughlin TJ, Gurwitz JH, Pearson S, Christiansen CL, Borbas C, Morris N, McLaughlin B, Gao X, Ross-Degnan D. Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance. Arch Intern Med. 1999 Sep 27; 159(17):2013-20.
    View in: PubMed
  159. Ross-Degnan D. Methods amidst madness: Strategies for evaluating the impacts of cost containment policies. Invited workshop at the Annual Meeting of the International Society for Pharmacoepidemiology, Boston, MA. 1999.
  160. Adams AS, Soumerai SB, Lomas J, Ross-Degnan D. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care. 1999 Jun; 11(3):187-92.
    View in: PubMed
  161. Gillman MW, Ross-Degnan D, McLaughlin TJ, Gao X, Spiegelman D, Hertzmark E, Goldman L, Soumerai SB. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction. J Am Geriatr Soc. 1999 May; 47(5):512-7.
    View in: PubMed
  162. Soumerai SB, Ross-Degnan D. Inadequate prescription-drug coverage for Medicare enrollees--a call to action. N Engl J Med. 1999 Mar 4; 340(9):722-8.
    View in: PubMed
  163. Ross-Degnan D. Contributions of behavioral perspectives to research on improving use of medicines. Invited plenary presentation at 4th Asia-Pacific Social Science and Medicine (APSSAM) Conference, Yogyakarta, Indonesia. 1998.
  164. Majumdar SR, Ross-Degnan D, Soumerai SB. A computer-assisted management program for antiinfective agents. N Engl J Med. 1998 Jun 11; 338(24):1775; author reply 1776.
    View in: PubMed
  165. Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization. Med Care. 1998 Mar; 36(3):321-32.
    View in: PubMed
  166. Donaldson D, Elvira Beracochea E, Fujisaki T, Mbugua M, Njeru A, Ross Degnan D, Sanchez M-P, Thuo HM. Partnerships in Reproductive Health. American Public Health Association Annual Meeting. 1998.
  167. Fujisaki T, Ross Degnan D, Sanchez M-P, Donaldson D, Thuo M, De Pass V, Berracochea E. The Cost Estimate Strategy (CES) for improving the availability and use of reproductive health commodities: Kenya field test report. 1998.
  168. Madden JM, Quick JD, Ross-Degnan D, Kafle KK. Undercover careseekers: simulated clients in the study of health provider behavior in developing countries. Soc Sci Med. 1997 Nov; 45(10):1465-82.
    View in: PubMed
  169. Soumerai SB, Ross-Degnan D. Insurance copayments and delays in seeking emergency care. N Engl J Med. 1997 Oct 23; 337(17):1247; author reply 1247-8.
    View in: PubMed
  170. Soumerai SB, Ross-Degnan D, Fortess EE, Walser BL. Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy? Milbank Q. 1997; 75(1):11-34.
    View in: PubMed
  171. Soumerai SB, Ross-Degnan D. Prescribing budgets: economic, clinical and ethical perspectives. Australian Prescriber. 1997; 20(2):28-29.
  172. Ross-Degnan D, Laing R, Santoso B, Ofori-Adjei D, Lamoureux C, Hogerzeil H. Improving pharmaceutical use in primary care in developing countries: a critical review of experience and lack of experience. Invited paper presented at the 1st International Conference for Improving Use of Medicines, Chiang Mai, Thailand. 1997.
  173. Ross-Degnan D. Investigating Drug Use. Management Sciences for Health, Managing Drug Supply. 1997.
  174. Ross-Degnan D. The role of clinical guidelines in the era of managed care. Invited presentation at the symposium Rational Drug Use - National and International Perspectives: Festshrift honoring Prof. Anthony Smith, Newcastle, Australia. 1997.
  175. Goel PK, Ross-Degnan D, McLaughlin TJ, Soumerai SB. Influence of location and staff knowledge on quality of retail pharmacy prescribing for childhood diarrhea in Kenya. Int J Qual Health Care. 1996 Dec; 8(6):519-26.
    View in: PubMed
  176. Ross-Degnan D, Soumerai SB, Goel PK, Bates J, Makhulo J, Dondi N, Adi D, Ferraz-Tabor L, Hogan R. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies. Health Policy Plan. 1996 Sep; 11(3):308-18.
    View in: PubMed
  177. Ross-Degnan D, Soumerai SB. HMO formularies and care costs. Lancet. 1996 May 4; 347(9010):1264.
    View in: PubMed
  178. Goel P, Ross-Degnan D, Berman P, Soumerai S. Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med. 1996 Apr; 42(8):1155-61.
    View in: PubMed
  179. Wilson MR, Mansour M, Atud AE, Casey R, Fobi G, Moukouri E, Alemayehu W, Martone JF, Ross-Degnan D. A population-based study of xerophthalmia in the extreme North Province of Cameroon, West Africa. Arch Ophthalmol. 1996 Apr; 114(4):464-8.
    View in: PubMed
  180. Wilson MR, Mansour M, Ross-Degnan D, Moukouri E, Fobi G, Alemayehu W, Martone JF, Casey R, Bazargan M. Prevalence and causes of low vision and blindness in the Extreme North Province of Cameroon, West Africa. Ophthalmic Epidemiol. 1996 Mar; 3(1):23-33.
    View in: PubMed
  181. INRUD Social Scientists Working Group. How to use applied qualitative methods to design drug use interventions. 1996.
  182. Ross-Degnan D. Behavioral interventions to improve the use of medicines: opportunities and experiences. Invited presentation to the Annual meeting of the Southeast Asia Clinical Epidemiology Network, Cebu, Philippines. 1996.
  183. Walser BL, Ross-Degnan D, Soumerai SB. Do open formularies increase access to clinically useful drugs? Health Aff (Millwood). 1996; 15(3):95-109.
    View in: PubMed
  184. INRUD Social Scientists Working Group. How to use applied qualitative methods to design drug use interventions. 1996.
  185. Ross-Degnan D. Interventions to improve the use of medicines in developing countries: The INRUD experience. Invited presentation to the Annual Meeting of the International Clinical Epidemiology Network, Victoria Falls, Zimbabwe. 1996.
  186. Laing RO, Ross-Degnan DG. National drug policies. Lancet. 1995 Dec 9; 346(8989):1561-2.
    View in: PubMed
  187. Schwab L, Whitfield R, Ross-Degnan D, Steinkuller P, Swartwood J. The epidemiology of trachoma in rural Kenya. Variation in prevalence with lifestyle and environment. Study Survey Group. Ophthalmology. 1995 Mar; 102(3):475-82.
    View in: PubMed
  188. Ross-Degnan D. Improving pharmaceutical use: A framework and some intervention strategies. Keynote address to Xth Annual Meeting of the Thailand Royal College of Physicians Pattaya, Thailand. 1995.
  189. Ross-Degnan D. Measuring the quality of pharmaceutical use with indicators: Defining problems and stimulating change. Symposium presentation at 7th Southeast Asia-Western Pacific Regional Meeting of Pharmacologists, Manila, Philippines. 1995.
  190. Ross-Degnan D, Soumerai SB, Avorn J, Bohn RL, Bright R, Aledort LM. Hemophilia home treatment. Economic analysis and implications for health policy. Int J Technol Assess Health Care. 1995; 11(2):327-44.
    View in: PubMed
  191. Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH. Withdrawal of a drug from the market: what should the prescriber do? JAMA. 1994 Oct 26; 272(16):1253.
    View in: PubMed
  192. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994 Sep 8; 331(10):650-5.
    View in: PubMed
  193. Ross-Degnan D and Laing RO. Quantitative methods for pharmacoepidemiology in developing countries. Annual Meeting of the International Society for Pharmacoepidemiology, Stockholm, Sweden. 1994.
  194. Ross-Degnan D and Laing RO. Indicators of appropriate antibiotic use: The development of standard measures and methods. 4th Western Pacific Congress of Chemotherapy and Infectious Disease, Manila, Philippines. 1994.
  195. Ross-Degnan D, Soumerai S, Long S, Hawley S. Medicaid formularies as a cost-containment tool: Do they really reduce costs?. American Public Health Association Annual Meeting, Washington D.C. 1994.
  196. Hogerzeil HV, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafle KK, Mabadeje AF, et al. Field tests for rational drug use in twelve developing countries. Lancet. 1993 Dec 4; 342(8884):1408-10.
    View in: PubMed
  197. Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH. Examining product risk in context. Market withdrawal of zomepirac as a case study. JAMA. 1993 Oct 27; 270(16):1937-42.
    View in: PubMed
  198. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA. A controlled trial of educational outreach to improve blood transfusion practice. JAMA. 1993 Aug 25; 270(8):961-6.
    View in: PubMed
  199. INRUD and WHO Action Programme on Essential Drugs. How to investigate drug use in health facilities: selected drug use indicators. (DAP Research Series N°7. WHO/DAP/93.1). 1993.
  200. Ross-Degnan D, Soumerai S, Goel P, Bates J. Guide for improving the diarrhoea treatment practice of pharmacists and licensed sellers of drugs. 1993.
  201. Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q. 1993; 71(2):217-52.
    View in: PubMed
  202. Ross-Degnan D. From confrontation to dialogue: Pharmaceutical politics in the 1990's. Review of Silverman M, Lydecker M, Lee PR. Bad Medicine: The Prescription Drug Industry in the Third World (1992; Stanford, California: Stanford University Press). Health Affairs. 1993; 12(2):208-10.
  203. INRUD and WHO Action Programme on Essential Drugs. How to investigate drug use in health facilities: selected drug use indicators. 1993.
  204. Ross-Degnan D, Soumerai SB, Long S, Hawley S. Feasibility of using aggregate annual data for evaluating the impacts of Medicaid cost containment policies. 1993.
  205. Ross-Degnan D, Laing R, Quick J, Ali HM, Ofori-Adjei D, Salako L, Santoso B. A strategy for promoting improved pharmaceutical use: the International Network for Rational Use of Drugs. Soc Sci Med. 1992 Dec; 35(11):1329-41.
    View in: PubMed
  206. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992 Jul 16; 327(3):168-73.
    View in: PubMed
  207. Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992 Jun 1; 116(11):901-4.
    View in: PubMed
  208. Ross-Degnan D, Soumerai S, McLaughlin T, Fortess E. Predictors of vulnerability to state drug payment restrictions. American Public Health Association Annual Meeting, Washington, D.C. 1992.
  209. Soumerai SB, Ross-Degnan D, Kahn JS. Effects of professional and media warnings about the association between aspirin use in children and Reye's syndrome. Milbank Q. 1992; 70(1):155-82.
    View in: PubMed
  210. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin Tj, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991 Oct 10; 325(15):1072-7.
    View in: PubMed
  211. Quick JD, Laing RO, Ross-Degnan DG. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol. 1991; 44 Suppl 2:57S-65S.
    View in: PubMed
  212. Soumerai SB, Ross-Degnan D. Drug prescribing in pediatrics: challenges for quality improvement. Pediatrics. 1990 Nov; 86(5):782-4.
    View in: PubMed
  213. Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA. 1990 Jul 25; 264(4):471-5.
    View in: PubMed
  214. Whitfield R, Schwab L, Ross-Degnan D, Steinkuller P, Swartwood J. Blindness and eye disease in Kenya: ocular status survey results from the Kenya Rural Blindness Prevention Project. Br J Ophthalmol. 1990 Jun; 74(6):333-40.
    View in: PubMed
  215. Soumerai SB, Ross-Degnan D, Gortmaker S, Avorn J. Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment. JAMA. 1990 Feb 9; 263(6):831-9.
    View in: PubMed
  216. Soumerai SB, Ross-Degnan D. Experience of state drug benefit programs. Health Aff (Millwood). 1990; 9(3):36-54.
    View in: PubMed
  217. Laing RO, Ross-Degnan DG. Report on the inaugural meeting of the International Network for Rational Use of Drugs. Jl Soc Admin Pharm. 1990; 7(3):144-46.
  218. Mason RP, Kosoko O, Wilson MR, Martone JF, Cowan CL, Gear JC, Ross-Degnan D. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology. 1989 Sep; 96(9):1363-8.
    View in: PubMed
  219. Fujisaki T, Ross Degnan D, Sanchez M-P, Donaldson D, Thuo M, De Pass V, Berracochea E. The Cost Estimate Strategy (CES) for improving the availability and use of reproductive health commodities: Kenya field test report. 1988.
  220. Quick JD, Foreman P, Ross-Degnan DG. . Where does the tetracycline go? Health center prescribing and child survival in Indonesia. 1988.
  221. Quick JD, Foreman P, Ross-Degnan DG. Where does the tetracycline go? Health center prescribing and child survival in Indonesia. 1988.
  222. Quick JD, Foreman P, Ross-Degnan DG, Kempner D, O'Connor R, Sacca S. Child survival pharmaceuticals in Nepal: Opportunities for expanded supply and improved use of pharmaceuticals. 1988.
  223. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med. 1987 Aug 27; 317(9):550-6.
    View in: PubMed
  224. Tabbara KF, Ross-Degnan D. Blindness in Saudi Arabia. JAMA. 1986 Jun 27; 255(24):3378-84.
    View in: PubMed
  225. Tabbara K, Ross Degnan D. Trachoma in Saudi Arabia: Results from a national eye examination survey. Archives Ophthalmol (in press, but withdrawn at the request of the Government of Saudi Arabia). 1986.
  226. Ross-Degnan D, Schwab L. The epidemiology of trachoma in Kenya. Annual Conference of the National Council for International Health. 1986.
  227. Quick J, Ross-Degnan D, Bimo, Santoso B. Why scabies kills: Pharmaceutical misallocations and child survival. American Public Health Association Annual Meeting. 1986.
  228. Ross Degnan D. Epidemiology of ocular infections. Tabbara KF and Hyndiuk RA, Infections of the Eye. 1986.
  229. Ross-Degnan D, Whitfield R. The use of computers for primary data capture in a large scale field setting. Public Health Conference on Records and Statistics. 1985.
  230. Whitfield R, Schwab L, Bakker NJ, Bisley GG, Ross-Degnan D. Cataract and corneal opacity are the main causes of blindness in the Samburu tribe of Kenya. Ophthalmic Surg. 1983 Feb; 14(2):139-44.
    View in: PubMed
  231. Ross-Degnan D, Schwab L, Mburu FM. Field methodology for ocular surveys in rural Africa. Soc Sci Med. 1983; 17(22):1793-6.
    View in: PubMed
  232. Ross Degnan D, Soumerai SB. Final evaluation report of the Cambridge Elderly Hot Lunch Program. 1979.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Ross-Degnan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_